Skip to main content
Livermore
Livermore
ZHEN

C4 Therapeutics, Inc.

CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001662579

No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding C4 Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of CCCC: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1152118+5
Shares60.9M4.68M64.2M+7.97M (+14.2%)
Value$281.3M$21.6M$365.9M+$106.2M (+40.9%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held C4 Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to CCCC in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.4,890,935$27.9M0.00%
Adage Capital Partners GP, L.L.C.520,000$2.96M0.01%
Marshall Wace, LLP225,416$1.28M0.00%
BIT Capital GmbH138,899$791.7K0.08%
XTX Topco Ltd84,951$484.2K0.04%
Wexford Capital LP55,231$314.8K0.08%
LMR Partners LLP51,000$290.7K0.01%
TD Asset Management Inc43,400$255.6K0.00%
AQR Capital Management LLC38,956$222.0K0.00%
Franklin Resources Inc34,383$202.2K0.00%
Vestcor Inc29,500$168.0K0.01%
Intech Investment Management LLC27,126$154.6K0.00%
SG Americas Securities, LLC24,941$142.0K0.00%
UBS Oconnor LLC23,000$131.1K0.00%
Engineers Gate Manager LP22,813$130.0K0.00%
HSBC Holdings PLC21,168$123.0K0.00%
Aigen Investment Management, LP14,344$81.8K0.02%
Ameriprise Financial Inc11,620$66.2K0.00%
ProShare Advisors LLC11,079$63.1K0.00%
Cynosure Management, LLC10,007$57.0K0.01%
Point72 (DIFC) Ltd8,873$50.6K0.00%
Morgan Dempsey Capital Management LLC1,500$8.55K0.00%
CWM, LLC1,018$6.00K0.00%
Advisor Group Holdings, Inc.530$3.02K0.00%
GAMMA Investing LLC217$1.24K0.00%
Sterling Capital Management LLC186$1.06K0.00%
Clear Street Markets LLC143$1.00K0.00%
Nisa Investment Advisors, LLC165$9410.00%
Lindbrook Capital, LLC100$5700.00%
Capital Performance Advisors LLP54$3080.00%
US Bancorp38$2170.00%

Sold out (26)

Institutions that held C4 Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of CCCC in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
TCG Crossover Management, LLC1,276,574$5.90M
Schroder Investment Management Group405,885$1.88M
Atom Investors LP332,620$1.54M
Qube Research & Technologies Ltd258,426$1.19M
Renaissance Technologies LLC235,200$1.09M
Capital Fund Management S.A.220,517$1.02M
Acadian Asset Management LLC113,436$524.0K
Bellevue Group AG57,600$266.1K
Alpine Global Management, LLC57,528$265.8K
Bridgeway Capital Management, LLC49,000$226.4K
Walleye Capital LLC39,976$184.7K
Brevan Howard Capital Management LP33,511$154.8K
Corton Capital Inc.31,959$147.7K
Catalyst Funds Management Pty Ltd23,228$107.3K
Aquatic Capital Management LLC20,700$95.6K
Fox Run Management, L.L.C.14,973$69.2K
Marathon Trading Investment Management LLC14,400$66.5K
E Fund Management Co., Ltd.11,280$52.1K
Tudor Investment Corp Et Al10,162$46.9K
Headlands Technologies LLC9,652$44.6K
Group One Trading, L.P.1,735$8.02K
Pacer Advisors, Inc.1,056$4.88K
Piscataqua Savings Bank600$2.77K
EntryPoint Capital, LLC458$2.12K
Federated Hermes, Inc.316$1.46K
Gradient Investments LLC25$116

Not filed for Q3 2024 yet (2)

Institutions that held C4 Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CCCC in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.4,551,510$21.0M
Susquehanna Fundamental Investments, LLC129,801$599.7K